In a city as dynamic and densely populated as Delhi, medical emergencies can occur anytime, anywhere. Whether it’s a road accident on a busy intersection, a sudden cardiac arrest at home, or a patient transfer between hospitals, timely medical transportation becomes a matter of life and death. That’s where GoAid Ambulance sets a new benchmark […]
Introduction: Why Long-Term Data Matters in Diabetes Care When initiating a new medication such as Mounjaro KwikPen 2.5 mg, both patients and healthcare professionals tend to focus beyond immediate outcomes. Although early observations like decreased hunger or minor side effects are significant, the question remains: What occurs in the long term? Clinical trials are the […]
Introduction Caberdost 0.5 mg contains a preparation of cabergoline, a D₂ receptor agonist of dopamine commonly employed to manage hyperprolactinemia and prolactin-secreting pituitary adenomas (prolactinomas). With compelling evidence supporting its ability to normalize prolactin and reduce tumor size, cabergoline has become the Gold Standard—generally used in place of bromocriptine—within the first-line strategy for both micro- and macroadenomas. This review discusses how Caberdost functions, its clinical efficacy, dosing regimens, safety issues, real-world insights, and patient monitoring suggestions. How Caberdost 0.5 mg Works Cabergoline is a dopamine agonist—acting like the inhibitory hormone dopamine to suppress prolactin release from pituitary lactotroph cells. Its long half-life (~63–69 hours) supports once- […]